Introduction to Amantadine
Amantadine is a medication that belongs to the adamantane antivirals drug class. It is commonly used to treat various conditions, including influenza A, Parkinson's disease, and extrapyramidal reactions. The drug is available in several forms, including oral capsules, oral liquid, and oral tablets.
Global Market Size and Growth
The global market for amantadine is expected to experience significant growth over the next few years. As of 2023, the global market for amantadine was estimated to be worth approximately $254 million. It is forecasted to reach $391.8 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period of 2024-2030[1][4].
Market Segmentation
By Type
The amantadine market is segmented into two main types based on purity:
- High Purity: This segment is expected to contribute significantly to the market growth due to its higher efficacy and demand.
- Low Purity: Although less preferred, this segment still holds a market share due to its lower cost and specific applications[1][4].
By Application
The market is also segmented based on the application of amantadine:
- Tablets Product: This is one of the most common forms of amantadine and accounts for a substantial portion of the market.
- Oral Solution: Used for patients who have difficulty swallowing tablets.
- Others: This includes other forms and uses of amantadine, such as in treating neurological disorders[1][4].
Regional Analysis
The amantadine market is spread across various regions, with different growth rates and market sizes:
- Europe: The European market for amantadine was valued at a significant amount in 2023 and is expected to grow steadily over the forecast period[1].
- North America: This region is a major market for anti-Parkinson drugs, including amantadine, driven by a high prevalence of Parkinson’s disease and other neurological disorders[3].
- Asia-Pacific: This region is expected to see significant growth due to increasing awareness and biotechnological advancements[3].
Key Players
The amantadine market is dominated by several key players:
- Chemoswed AB
- Rochem International Inc
- Apeloa Pharmaceutical Co
- Hangzhou Longshine Bio-Tech Co
- Northeast Pharmaceutical Group Co
- Zhejiang Apeloa Kangyu Pharmaceutical Co
- Jiangxi Dongxu Chemical Science And Technology Co[1].
Price Projections and Affordability
Pricing Variability
The cost of amantadine can vary significantly based on the form and quantity of the medication. For example:
- Oral Capsule: A 30-day supply of 100 mg oral capsules can cost around $26.38, with the price per unit decreasing as the quantity increases[2].
- Oral Liquid: A 200 milliliter supply of 50 mg/5 mL oral liquid can cost around $19.34[2].
- Oral Tablet: A 100-tablet supply of 100 mg oral tablets can cost around $78.00[2].
Discounts and Assistance Programs
To make amantadine more affordable, various discount cards, coupons, and patient assistance programs are available. For instance, the Drugs.com Discount Card can save consumers up to 80% on prescription medicines[2].
Driving Factors and Trends
Increasing Flu Cases
The rise in influenza A cases is a significant driver for the amantadine market, as it is one of the primary treatments for this condition[4].
Need for Treatments for Neurological Disorders
The growing need for effective treatments for Parkinson’s disease and other neurological disorders also drives the demand for amantadine[4].
Biotechnological Advancements
Advancements in biotechnology and the development of new formulations and delivery methods are expected to boost the market growth[3].
Challenges
High Cost of Treatment
One of the major challenges facing the amantadine market is the high cost of treatment, particularly for Parkinson’s disease. The economic burden of Parkinson’s disease is significant, with annual costs in the United States estimated at $51.9 billion[3].
Key Takeaways
- The global amantadine market is projected to grow from $254 million in 2023 to $391.8 million by 2030, with a CAGR of 6.4%.
- The market is segmented into high purity and low purity types, and by applications such as tablets, oral solutions, and others.
- Key players include Chemoswed AB, Rochem International Inc, and Apeloa Pharmaceutical Co, among others.
- The cost of amantadine varies by form and quantity, with discounts and assistance programs available to make it more affordable.
- Increasing flu cases and the need for treatments for neurological disorders are significant drivers of the market.
FAQs
What is the projected market size of amantadine by 2030?
The global market for amantadine is expected to reach $391.8 million by 2030[1].
What is the CAGR of the amantadine market from 2024 to 2030?
The amantadine market is expected to grow at a CAGR of 6.4% during the forecast period of 2024-2030[1].
What are the main applications of amantadine?
The main applications of amantadine include treating influenza A, Parkinson’s disease, and extrapyramidal reactions. It is available in forms such as tablets, oral solutions, and others[1][2].
Who are the key players in the amantadine market?
Key players in the amantadine market include Chemoswed AB, Rochem International Inc, Apeloa Pharmaceutical Co, and several others[1].
How can consumers make amantadine more affordable?
Consumers can use discount cards, coupons, and patient assistance programs to make amantadine more affordable. For example, the Drugs.com Discount Card can save up to 80% on prescription medicines[2].
Sources
- Valuates Reports: Amantadine - Market, Report Size, Worth, Revenue, Growth, Industry...
- Drugs.com: Amantadine Prices, Coupons, Copay Cards & Patient Assistance
- The Business Research Company: Global Anti-Parkinson Drugs Market Report 2024
- Proficient Market Insights: Amantadine Market Growth, Shares and Forecast 2031
